Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Paul Campbell Appointment

1st Oct 2007 11:03

Smith & Nephew Plc01 October 2007 SMITH & NEPHEW ADVANCED WOUND MANAGEMENT APPOINTS PAUL CAMPBELL AS VICEPRESIDENT OF STRATEGIC MARKETING Hull, ENG. and Largo, FL, October 1, 2007 -Smith & Nephew's (LSE: SN; NYSE:SNN)Advanced Wound Management division today announced the appointment of PaulCampbell as Vice President of Strategic Marketing for its Advanced Wound CareStrategic Business Unit (SBU). Campbell joins Smith & Nephew from J&J Medical, where he commencedhis career in regional Territory Management and Marketing Management roles forETHICON Sutures followed by a Product Director role, a Franchise Manager role,European Business Manager for Haemostasis products and latterly as GroupMarketing Director Worldwide for Surgical Meshes. These roles spanned variousgeographies, and he has lived and worked in France, Israel, Turkey, the US aswell as the UK. "Paul has worked in the medical device industry for the last 18 years withparticular focus in Sales and Marketing. In that time he has gained a broadrange of international experience and has demonstrated success in a number ofsenior management positions", commented Roger Teasdale Senior Vice President. In this role Campbell will report to Roger Teasdale, Senior Vice President ofthe Advanced Wound Care SBU. Campbell holds a Masters in Languages and an MBA from the University ofEdinburgh. FOR IMMEDIATE RELEASE Contact: Sidonie Myers Smith & Nephew Advanced Wound Management + 44 1482 673246 About Smith & Nephew: Smith & Nephew is a global medical technology business, specialising inOrthopaedic Reconstruction, Orthopaedic Trauma and Clinical Therapies, Endoscopyand Advanced Wound Management products. Smith & Nephew is a global leader inarthroscopy and advanced wound management and is one of the leading globalorthopaedics companies. Smith & Nephew is dedicated to helping improve people's lives. The Companyprides itself on the strength of its relationships with its surgeons andprofessional healthcare customers, with whom its name is synonymous with highstandards of performance, innovation and trust. The Company has 9,600 employeesand operates in 31 countries around the world. Annual sales in 2006 were nearly$2.8 billion. ### This information is provided by RNS The company news service from the London Stock Exchange

Related Shares:

Smith & Nephew
FTSE 100 Latest
Value8,275.66
Change0.00